Miv Therapeutics, Inc. (IVT) Misses Q3 EPS by 5c
Tweet
Share
E-mailGet Alerts IVT Hot Sheet
Join SI Premium – FREE
Miv Therapeutics, Inc. (NYSE: IVT) reported Q3 EPS of ($0.01), $0.05 worse than the analyst estimate of $0.04.
For earnings history and earnings-related data on Miv Therapeutics, Inc. (IVT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- Benchmark Reiterates Speculative Buy Rating on Nephros (NEPH) Following Strong Q2 Results
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
